These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36439506)

  • 1. Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer.
    Wumener X; Zhang Y; Wang Z; Zhang M; Zang Z; Huang B; Liu M; Huang S; Huang Y; Wang P; Liang Y; Sun T
    Front Oncol; 2022; 12():1005924. PubMed ID: 36439506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.
    Wumener X; Zhang Y; Zang Z; Ye X; Zhao J; Zhao J; Liang Y
    Ann Nucl Med; 2024 Jul; ():. PubMed ID: 39078558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
    Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
    BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.
    Budiawan H; Cheon GJ; Im HJ; Lee SJ; Paeng JC; Kang KW; Chung JK; Lee DS
    Nucl Med Mol Imaging; 2013 Dec; 47(4):232-41. PubMed ID: 24900118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT.
    Lee AY; Choi SJ; Jung KP; Park JS; Lee SM; Bae SK
    Nucl Med Mol Imaging; 2014 Mar; 48(1):41-6. PubMed ID: 24900137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative parameters of static imaging and fast kinetics imaging in
    Meng N; Zhang M; Ren J; Fu F; Xie B; Wu Y; Li Z; Dai B; Li Y; Feng T; Xu T; Wang M
    Quant Imaging Med Surg; 2023 Sep; 13(9):5579-5592. PubMed ID: 37711783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary clinical assessment of dynamic
    Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M
    Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
    Choi EK; Park HL; Yoo IR; Kim SJ; Kim YK
    Eur Radiol; 2020 Jan; 30(1):442-451. PubMed ID: 31338654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging.
    Giesel FL; Schneider F; Kratochwil C; Rath D; Moltz J; Holland-Letz T; Kauczor HU; Schwartz LH; Haberkorn U; Flechsig P
    J Nucl Med; 2017 Feb; 58(2):282-287. PubMed ID: 27660141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of dynamic
    Sun Y; Xiao L; Wang Y; Liu C; Cao L; Zhai W; Wang B; Yu S; Xin J
    Quant Imaging Med Surg; 2023 Apr; 13(4):2556-2567. PubMed ID: 37064404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Shigemoto Y; Suga K; Matsunaga N
    Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
    Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of [
    Deleu AL; Laenen A; Decaluwé H; Weynand B; Dooms C; De Wever W; Jentjens S; Goffin K; Vansteenkiste J; Van Laere K; De Leyn P; Nackaerts K; Deroose CM
    EJNMMI Res; 2022 May; 12(1):28. PubMed ID: 35524900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of Mediastinal Lymph Node SUV to Primary Tumor SUV in
    Cho J; Choe JG; Pahk K; Choi S; Kwon HR; Eo JS; Seo HJ; Kim C; Kim S
    Nucl Med Mol Imaging; 2017 Jun; 51(2):140-146. PubMed ID: 28559938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of
    Cha J; Kim S; Wang J; Yun M; Cho A
    Nucl Med Mol Imaging; 2018 Feb; 52(1):39-45. PubMed ID: 29391911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
    Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
    Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.